Research News

September
29,
2023
| 08:00 AM America/Los_Angeles
$25M Gift Creates Alfred E. Mann Precision Medicine Innovation CenterAlfred E. Mann Charities, Inc., has just announced a $25 million gift to the Cedars-Sinai Board of Governors. The gift will establish the Alfred E. Mann Single Cell Precision
September
29,
2023
| 06:00 AM America/Los_Angeles
Lifestyle changes made during the COVID-19 pandemic—such as increased hand washing and use of disinfectants—may have led to changes in the gut microbiome, according to investigators at Cedars-Sinai.Scientists compared the small intestine luminal
September
28,
2023
| 08:00 AM America/Los_Angeles
Cedars-Sinai recently announced the selection of Joshua Levy, PhD, as the new director of Digital Pathology Research. Levy also will hold a joint appointment in the Department of Computational Biomedicine.Levy’s research focuses on implementing AI,
September
19,
2023
| 06:30 AM America/Los_Angeles
In 1998, scientists reported being able to derive cells from human embryos that could develop into almost any cell in the body. In 2007, the field took a huge leap when scientists discovered they could reprogram human adult skin cells to act like
September
13,
2023
| 06:00 AM America/Los_Angeles
Heavy alcohol consumption is associated with acute and repeated episodes of pancreatitis, an inflammatory condition that can cause severe abdominal pain and death. According to a new study published in the peer-reviewed journal Gastro Hep Advances,
September
12,
2023
| 08:00 AM America/Los_Angeles
Investigators from the Smidt Heart Institute at Cedars-Sinai have found that community-level socioeconomic disparities are associated with worse three-year survival rates for patients with degenerative mitral regurgitation who had valve repair
September
08,
2023
| 09:00 AM America/Los_Angeles
A large nationwide survey of 89,000 people conducted by Cedars-Sinai investigators found the prevalence of irritable bowel syndrome (IBS) to be higher than previously reported: 6.1% compared with 4.7% to 5.3% in studies of significantly smaller
September
05,
2023
| 06:30 AM America/Los_Angeles
Investigators from the Cedars-Sinai Board of Governors Regenerative Medicine Institute and Cedars-Sinai Cancer have collaborated to co-develop and test a new version of the chemotherapy workhorse doxorubicin. Their study, published in the
August
31,
2023
| 15:30 PM America/Los_Angeles
Cedars-Sinai investigators are leaders in the innovation and use of transcatheter aortic valve replacement (TAVR) with balloon-expandable valves. They now show that redo TAVR procedures are both safe and effective when compared with situations in